학술논문
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma
Document Type
Article
Author
Catenacci, D.V.T.; Kang, Y.-K.; Uronis, H.E.; Lee, K.-W.; Ng, M.C.H.; Enzinger, P.C.; Park, S.H.; Gold, P.J.; Lacy, J.; Hochster, H.S.; Oh, S.C.; Kim, Y.H.; Marrone, K.A.; Kelly, R.J.; Juergens, R.A.; Kim, J.G.; Alcindor, T.; Sym, S.J.; Song, E.-K.; Chee, C.E.; Chao, Y.; Kim, S.; Oh, D.-Y.; Yen, J.; Odegaard, J.I.; Lagow, E.; Li, D.; Sun, J.; Kaminker, P.; Moore, P.A.; Rosales, M.K.; Park, H.
Source
In: ONCOLOGY (United States) . (ONCOLOGY (United States), April 2023, 37(4):176-183)
Subject
Language
English
ISSN
08909091